MEDICAL SERVICES

EDUCATION

Medical School

  • University of Athens Medical School , 2008 , Athens , Greece

Internship

Pediatrics
  • Children's Medical Center at Dallas , 2012 , Dallas , TX

Graduate Degree

PhD, Immunopharmacology
  • University of Athens Medical School , 2013 , Athens , Greece

Residency

Pediatrics
  • Children's Medical Center at Dallas , 2014 , Dallas , TX

Fellowship

  • Harvard Neonatal-Perinatal Medicine Training Program , 2016 , Boston , MA

Philosophy of Care

In the Boston Children’s Hospital (BCH) Neonatal Intensive Care Unit (NICU) our philosophy is to ensure that every patient receives the best care for the best possible outcomes. We consider our “patient” to be the baby and the family; we are constantly striving to serve the needs of both. This requires a team based approach with all members being essential. The future of any society depends on its ability to foster the health and well-being of the next generation. This is the reason I chose to become a pediatrician. As a neonatologist at Boston Children’s Hospital, I am devoted to serving our smallest and most vulnerable patients by integrating highly specialized clinical care with rigorous translational science. I put great emphasis on establishing trusting relationships with families and integrating parental values in decision-making

PROFESSIONAL HISTORY

Asimenia Angelidou, MD, PhD obtained her medical degree and doctoral degree in Immunopharmacology from the University of Athens in Greece. She completed her pediatric residency training at the University of Texas Southwestern and Children’s Medical Center at Dallas, TX, and her clinical fellowship in Neonatal-Perinatal Medicine at the Harvard Combined Training Program in Neonatology where she also served as Chief Fellow. She is currently an attending Neonatologist at the Boston Children’s Hospital Neonatal Intensive Care Unit and Instructor at Harvard Medical School.Dr. Angelidou has a special interest in neonatal trained immunity. Under the mentorship of Drs. Ofer Levy and Mihai Netea, she focused on newborn innate immune ontogeny and the role of vaccine-induced "heterologous protection" against unrelated pathogens, research for which she received the Marshall Klaus Perinatal Research Award from the American Academy of Pediatrics.

CERTIFICATIONS

  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Neonatal-Perinatal Medicine

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Angelidou A, Michael Z, Hotz A, Friedman K, Emani S, LaRovere K, Christou H. Is There More to Zika? Complex Cardiac Disease in a Case of Congenital Zika Syndrome. Neonatology. 2018; 113(2):177-182. View abstract
  2. Angelidou A, Bell K, Gupta M, Tropea Leeman K, Hansen A. Implementation of a Guideline to Decrease Use of Acid-Suppressing Medications in the NICU. Pediatrics. 2017 Dec; 140(6). View abstract
  3. Alysandratos KD, Asadi S, Angelidou A, Zhang B, Sismanopoulos N, Yang H, Critchfield A, Theoharides TC. Neurotensin and CRH interactions augment human mast cell activation. PLoS One. 2012; 7(11):e48934. View abstract
  4. Angelidou A, Asadi S, Alysandratos KD, Karagkouni A, Kourembanas S, Theoharides TC. Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatr. 2012 Jul 02; 12:89. View abstract
  5. Zhang B, Weng Z, Sismanopoulos N, Asadi S, Therianou A, Alysandratos KD, Angelidou A, Shirihai O, Theoharides TC. Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells. Int Arch Allergy Immunol. 2012; 159(1):23-32. View abstract
  6. Theoharides TC, Enakuaa S, Sismanopoulos N, Asadi S, Papadimas EC, Angelidou A, Alysandratos KD. Contribution of stress to asthma worsening through mast cell activation. Ann Allergy Asthma Immunol. 2012 Jul; 109(1):14-9. View abstract
  7. Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Vasiadi M, Therianou A, Theoharides TC. IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One. 2012; 7(3):e33271. View abstract
  8. Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Therianou A, Kalogeromitros D, Theoharides TC. Mast cells in allergic and inflammatory diseases. Curr Pharm Des. 2012; 18(16):2261-77. View abstract
  9. Asadi S, Alysandratos KD, Angelidou A, Miniati A, Sismanopoulos N, Vasiadi M, Zhang B, Kalogeromitros D, Theoharides TC. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol. 2012 Feb; 132(2):324-9. View abstract
  10. Angelidou A, Alysandratos KD, Asadi S, Zhang B, Francis K, Vasiadi M, Kalogeromitros D, Theoharides TC. Brief report: "allergic symptoms" in children with Autism Spectrum Disorders. More than meets the eye? J Autism Dev Disord. 2011 Nov; 41(11):1579-85. View abstract
  11. Zhang B, Alysandratos KD, Angelidou A, Asadi S, Sismanopoulos N, Delivanis DA, Weng Z, Miniati A, Vasiadi M, Katsarou-Katsari A, Miao B, Leeman SE, Kalogeromitros D, Theoharides TC. Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis. J Allergy Clin Immunol. 2011 Jun; 127(6):1522-31.e8. View abstract
  12. Theoharides TC, Angelidou A, Alysandratos KD, Zhang B, Asadi S, Francis K, Toniato E, Kalogeromitros D. Mast cell activation and autism. Biochim Biophys Acta. 2012 Jan; 1822(1):34-41. View abstract
  13. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D. Mast cells and inflammation. Biochim Biophys Acta. 2012 Jan; 1822(1):21-33. View abstract
  14. Zhang B, Angelidou A, Alysandratos KD, Vasiadi M, Francis K, Asadi S, Theoharides A, Sideri K, Lykouras L, Kalogeromitros D, Theoharides TC. Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children. J Neuroinflammation. 2010 Nov 17; 7:80. View abstract
  15. Alysandratos KD, Angelidou A, Vasiadi M, Zhang B, Kalogeromitros D, Katsarou-Katsari A, Theoharides TC. Increased affected skin gene expression and serum levels of thymic stromal lymphopoietin in atopic dermatitis. Ann Allergy Asthma Immunol. 2010 Nov; 105(5):403-4. View abstract
  16. Asadi S, Zhang B, Weng Z, Angelidou A, Kempuraj D, Alysandratos KD, Theoharides TC. Luteolin and thiosalicylate inhibit HgCl(2) and thimerosal-induced VEGF release from human mast cells. Int J Immunopathol Pharmacol. 2010 Oct-Dec; 23(4):1015-20. View abstract
  17. Angelidou A, Francis K, Vasiadi M, Alysandratos KD, Zhang B, Theoharides A, Lykouras L, Sideri K, Kalogeromitros D, Theoharides TC. Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation. 2010 Aug 23; 7:48. View abstract
  18. Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, Alysandratos KD, Kalogeromitros D, Asadi S, Stavrianeas N, Peterson E, Leeman S, Conti P. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A. 2010 Mar 02; 107(9):4448-53. View abstract
  19. Angelidou A, Strintzis MG, Panas S, Anogianakis G. On AR modelling for MEG spectral estimation, data compression and classification. Comput Biol Med. 1992 Nov; 22(6):379-87. View abstract